Table: Rohto -2021/22 group results

Rohto Pharmaceutical

12/05/2022 07:00

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            199.65          181.29         218.00                 
                                 (-3.7 pct)     (+9.2 pct)               
  Operating         29.35           22.99          28.00                 
                                 (-0.4 pct)     (-4.6 pct)               
  Recurring         29.08           23.91          28.00                 
                                 (+5.2 pct)     (-3.7 pct)               
  Net
  Net               21.02           16.74          19.50                 
                                 (+8.6 pct)     (-7.2 pct)               
  EPS            184.26 yen      146.78 yen     170.95 yen               
  EPS Diluted    183.73 yen      146.36 yen                              
  Ann Div         36.00 yen       28.00 yen      37.00 yen               
  -Q2 Div         15.00 yen       13.00 yen      18.00 yen               
  -Q4 Div         21.00 yen       15.00 yen      19.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T